The use of genistein and ambroxol may be an effective approach in correcting cellular dysfunctions of mucopolysaccharidosis-plus syndrome. [PDF]
Cyske Z +4 more
europepmc +1 more source
A.1 Repurposing Ambroxol as a disease-modifying treatment for Parkinson’s disease dementia: A phase 2, randomized, double blind placebo-controlled trial [PDF]
SH Pasternak +14 more
openalex +1 more source
Pathological Protein Targets in Parkinson's Disease: Progress Towards the Development of Disease-Modifying Therapies. [PDF]
Dzamko N.
europepmc +1 more source
Pulmonary Alveolar Proteinosis Successfully Treated with Ambroxol.
Toshihiko Hashizume
openalex +2 more sources
Ambroxol reverses tau and α-synuclein accumulation in a cholinergic N370S GBA1 mutation model
Shi Yu Yang +3 more
openalex +1 more source
Erratum: Ambroxol enhances anti-cancer effect of microtubule-stabilizing drug to lung carcinoma through blocking autophagic flux in lysosome-dependent way. [PDF]
Zhang X +7 more
europepmc +1 more source
Targeted delivery of glucocerebrosidase to lysosomes: The LYSOTAC (LYSOsome-TArgeting Chimera) technology. [PDF]
Kim HY +11 more
europepmc +1 more source

